1800 202 8726
PET-CT for urological cancers

PET-CT for Urological Cancers: — The Tracer Decides the Cost

For kidney and prostate cancer, the standard FDG PET-CT scan frequently misses disease — and patients are often not told this until after they have paid for it. The tracer matters as much as the scanner, and choosing the wrong one can mean a repeat scan.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

  • FDG does not suit every urological cancer — For prostate and kidney cancer, standard FDG PET-CT frequently misses disease or gives misleading results.
  • PSMA PET-CT was built for prostate cancer — It attaches to a protein on prostate cancer cells that FDG cannot target, giving far clearer images.
  • The tracer is the main cost driver — PSMA tracers require specialist production — which is why PSMA PET-CT costs roughly double a standard FDG scan.
  • Your oncologist specifies the tracer — Ask what is written on your referral before you book. Not all centres stock all tracers.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

PET-CT cost for urological cancers depends on which tracer is used, not just the scan itself. Bladder cancer generally uses FDG. Prostate cancer requires PSMA PET-CT, which typically costs roughly double. Kidney cancer is a special case — FDG performs poorly here, and your oncologist may recommend a different approach.

A whole-body PET-CT at CION costs from Rs 10,499 — among the lowest published prices in Hyderabad. Indicative price, as of September 2026.

Why does FDG PET-CT miss prostate and kidney cancer?

FDG PET-CT misses prostate cancer because prostate cancer cells typically have low glucose metabolism — the property FDG relies on to detect tumour activity. ASCO and ESMO both flag this limitation explicitly in their imaging guidance.

Kidney imaging adds a different problem. The kidneys naturally clear FDG into the urine, creating a bright background signal in the renal area — the exact region being examined — which can mask lesions.

Bladder cancer is different. FDG is the more commonly used tracer for bladder cancer staging. Urinary excretion still affects the scan technique, and the referral should specify this.

What do FDG, PSMA and PET-CT mean?

FDG
Fluorodeoxyglucose — a radioactive form of glucose and the most widely used PET tracer. Produced in high volumes and widely available, making it less expensive than specialist tracers. Performs poorly for prostate cancer and is complicated by urinary excretion when imaging the kidney area.
PSMA
Prostate-Specific Membrane Antigen — a protein expressed at high levels on prostate cancer cells. A PSMA-tagged tracer targets this protein directly and is far more sensitive than FDG for prostate cancer, particularly at early recurrence or when PSA levels are low.
Tracer
The radioactive substance injected before a PET scan. It determines what the scan can detect, which centre can perform it, and most of the cost. Different cancers need different tracers — the word 'PET-CT' alone does not tell you which one is being used.
PET-CT
A combined scan showing metabolic activity (PET) overlaid on anatomy (CT). The two images are read together to locate disease precisely. A PET-CT report describes findings — your oncologist interprets those findings in the context of your full clinical picture.

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

PET-CT Partner Centres

PET-CT Scan Centres in Hyderabad

CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.

These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

How does your doctor decide which scan to refer you for?

  1. Cancer type and clinical question reviewed

    Your oncologist considers your cancer type, current treatment status, and what the scan is meant to answer — staging, response assessment, or checking for recurrence.

  2. Tracer selected based on cancer biology

    For prostate cancer, PSMA is appropriate in most situations. For bladder cancer staging, FDG is more commonly used. For kidney cancer, the appropriate approach depends on the specific clinical question.

  3. Referral written with tracer specified

    The referral should name the tracer explicitly — not just 'PET-CT'. If it does not, ask before you book. The cost difference is significant and not all centres stock all tracers.

  4. Scan done at a partner imaging centre

    CION coordinates PET-CT through partner imaging centres. Your team will direct you to the appropriate facility for the tracer required. Confirm the appointment includes the right tracer before attending.

  5. Report returned to your oncologist

    The PET-CT report describes findings. Your oncologist interprets those findings in the context of your full clinical picture. The scan does not determine a diagnosis on its own.

Why does PSMA PET-CT cost roughly double the FDG scan?

FDG is produced in large volumes at cyclotron facilities and has become widely available across India. The lower cost reflects that established scale.

PSMA tracers require specialist radiopharmacy production and have a very short radioactive half-life. Each batch must be produced close to the time of the scan, and not every city has local production capacity. These logistics are reflected in the price.

Any figure quoted here would be dated by the time you read it. Confirm the current price with the imaging centre when your scan is referred. If cost is a concern, raise it with your oncologist before the scan date rather than after.

Did you know?

PSMA PET-CT was adopted into routine clinical practice because standard FDG PET-CT was failing to detect prostate cancer recurrence at the point when treatment decisions still had meaningful options — particularly when PSA levels were low.

If you were told a previous scan was clear and your PSA has since risen, ask your oncologist whether a PSMA scan is now indicated.

Source: EANM/SNMMI joint practice guidelines for prostate-specific membrane antigen PET imaging

PET-CT at CION starts from Rs 10,499 — among the lowest published prices in Hyderabad — across 4 partner centres in Banjara Hills, Punjagutta, Himayatnagar and Narayanaguda. Indicative price, as of September 2026.

Explore 100 more PET-CT for Your Cancer Type topics

All PET-CT for Your Cancer Type →

Your next step

Talk to an oncologist about your scan

Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Which PET-CT do I need for prostate cancer?

Almost always PSMA PET-CT, not standard FDG. Prostate cancer cells are typically low in glucose metabolism, so FDG frequently misses the disease or understates its extent — particularly at early recurrence. PSMA tracers attach to a protein expressed at high levels on prostate cancer cells, making them far more sensitive. If your referral says FDG for prostate cancer restaging, ask your oncologist whether PSMA is the more appropriate option.

Can I use a cheaper FDG scan for kidney cancer?

In many situations, FDG is not a reliable choice for kidney cancer — the kidneys naturally clear FDG into the urine, creating a bright background signal in the renal area that can mask lesions. A cheaper scan that misses disease is not a saving. In some clinical situations FDG still provides useful information for kidney cancer. Tell your oncologist you are concerned about cost and ask directly what a less expensive scan would and would not show.

How much does PSMA PET-CT cost in Hyderabad?

Prices vary by centre and change over time, so no figure here would be reliable by the time you read it. What is consistent is that PSMA PET-CT costs roughly double a standard FDG scan — the difference comes from specialist tracer production, not from the scanner itself. Ask the imaging centre for a current quote when your oncologist refers you. If cost is a concern, raise it before the scan date rather than after.

Does CION have its own PET-CT scanner?

CION does not operate its own PET-CT scanners. Scans are coordinated through partner imaging centres, and your oncologist's team will direct you to the appropriate facility for the tracer you need. Not all centres stock all tracers — PSMA in particular is less widely available than FDG — so the referral will specify both the scan type and the centre. If the location is inconvenient, ask whether an alternative centre nearby can provide the same tracer.

Will insurance cover PSMA PET-CT?

Coverage varies between insurers and policies. Many standard health insurance plans in India routinely cover FDG PET-CT but have not extended coverage to PSMA PET-CT, which is a newer study. Some higher-tier policies do cover it. Check with your insurer before the scan date, ask for confirmation in writing, and find out whether pre-authorisation is required. If the scan is not covered, discuss with your oncologist whether the clinical approach changes.

My PSA is rising after treatment but my last scan was clear — what should I do?

A clear result on FDG PET-CT does not rule out prostate cancer recurrence — particularly when PSA levels were low at the time of scanning. If your previous scan was FDG, ask your oncologist specifically whether PSMA PET-CT is now indicated. PSMA is substantially more sensitive for prostate cancer recurrence at low PSA levels, and a rising PSA with a previously clear scan is exactly the clinical situation where this question is most worth asking.

Call now Book free consultation